Literature DB >> 26883642

Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and Regeneration.

Warin Krityakiarana1,2, Paul M Zhao3, Kevin Nguyen3, Fernando Gomez-Pinilla4,5, Naiphinich Kotchabhakdi6, Jean de Vellis3, Araceli Espinosa-Jeffrey7.   

Abstract

Trophic factor treatment has been shown to improve the recovery of brain and spinal cord injury (SCI). In this study, we examined the effects of TSC1 (a combination of insulin-like growth factor 1 and transferrin) 4 and 8 h after SCI at the thoracic segment level (T12) in nestin-GFP transgenic mice. TSC1 treatment for 4 and 8 h increased the number of nestin-expressing cells around the lesion site and prevented Wallerian degeneration. Treatment with TSC1 for 4 h significantly increased heat shock protein (HSP)-32 and HSP-70 expression 1 and 2 mm from lesion site (both, caudal and rostral). Conversely, the number of HSP-32 positive cells decreased after an 8-h TSC1 treatment, although it was still higher than in both, non-treated SCI and intact spinal cord animals. Furthermore, TSC1 increased NG2 expressing cell numbers and preserved most axons intact, facilitating remyelination and repair. These results support our hypothesis that TSC1 is an effective treatment for cell and tissue neuroprotection after SCI. An early intervention is crucial to prevent secondary damage of the injured SC and, in particular, to prevent Wallerian degeneration.

Entities:  

Keywords:  Heat shock proteins; IGF-1; Myelin; Oligodendrocytes; Transferrin; Wallerian degeneration

Mesh:

Substances:

Year:  2016        PMID: 26883642      PMCID: PMC5352162          DOI: 10.1007/s11064-016-1850-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  99 in total

1.  Vascular niche for adult hippocampal neurogenesis.

Authors:  T D Palmer; A R Willhoite; F H Gage
Journal:  J Comp Neurol       Date:  2000-10-02       Impact factor: 3.215

2.  In vitro injury model for oligodendrocytes: development, injury, and recovery.

Authors:  A E De Los Monteros; P M Zhao; J De Vellis
Journal:  Microsc Res Tech       Date:  2001-03-15       Impact factor: 2.769

3.  Apotransferrin decreases the response of oligodendrocyte progenitors to PDGF and inhibits the progression of the cell cycle.

Authors:  P M Paez; C I Garcia; E F Soto; J M Pasquini
Journal:  Neurochem Int       Date:  2006-04-18       Impact factor: 3.921

4.  Characterization of cultured rat oligodendrocytes proliferating in a serum-free, chemically defined medium.

Authors:  R P Saneto; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Expression of heat shock protein (HSP)-25 and HSP-32 in the rat spinal cord reconstructed with Neurogel.

Authors:  Stéphane Woerly; Oluwole Awosika; Paul Zhao; Chioma Agbo; Fernando Gomez-Pinilla; Jean de Vellis; Araceli Espinosa-Jeffrey
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

6.  IGF-I specifically enhances axon outgrowth of corticospinal motor neurons.

Authors:  P Hande Ozdinler; Jeffrey D Macklis
Journal:  Nat Neurosci       Date:  2006-10-22       Impact factor: 24.884

7.  Spinal cord reconstruction using NeuroGel implants and functional recovery after chronic injury.

Authors:  S Woerly; V D Doan; F Evans-Martin; C G Paramore; J D Peduzzi
Journal:  J Neurosci Res       Date:  2001-12-15       Impact factor: 4.164

8.  Endogenous repair after spinal cord contusion injuries in the rat.

Authors:  M S Beattie; J C Bresnahan; J Komon; C A Tovar; M Van Meter; D K Anderson; A I Faden; C Y Hsu; L J Noble; S Salzman; W Young
Journal:  Exp Neurol       Date:  1997-12       Impact factor: 5.330

9.  Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.

Authors:  D A Loeffler; J R Connor; P L Juneau; B S Snyder; L Kanaley; A J DeMaggio; H Nguyen; C M Brickman; P A LeWitt
Journal:  J Neurochem       Date:  1995-08       Impact factor: 5.372

10.  Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice.

Authors:  Daniela Tropea; Emanuela Giacometti; Nathan R Wilson; Caroline Beard; Cortina McCurry; Dong Dong Fu; Ruth Flannery; Rudolf Jaenisch; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

View more
  3 in total

1.  Executive Dysfunction Early Postnatal Biomarkers among Children Born Extremely Preterm.

Authors:  Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-06       Impact factor: 4.147

Review 2.  Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers.

Authors:  Michael Yamakawa; Samuel M Santosa; Neeraj Chawla; Evguenia Ivakhnitskaia; Matthew Del Pino; Sebastian Giakas; Arnold Nadel; Sneha Bontu; Arjun Tambe; Kai Guo; Kyu-Yeon Han; Maria Soledad Cortina; Charles Yu; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-03-12       Impact factor: 3.770

Review 3.  Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers.

Authors:  Sangiliyandi Gurunathan; Min-Hee Kang; Jin-Hoi Kim
Journal:  Cancers (Basel)       Date:  2020-06-13       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.